The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence and prognostic impact of KRAS and BRAF mutations in patients undergoing liver surgery for colorectal metastases.
Georgios Karagkounis
No relevant relationships to disclose
Michael S. Torbenson
No relevant relationships to disclose
Hubert D Daniel
No relevant relationships to disclose
Nilofer Saba Azad
No relevant relationships to disclose
Luis A. Diaz
No relevant relationships to disclose
Ross C. Donehower
No relevant relationships to disclose
Kenzo Hirose
No relevant relationships to disclose
Timothy M. Pawlik
No relevant relationships to disclose
Michael A. Choti
No relevant relationships to disclose